FDA Inspection
Hybrid Pharma LLCHybrid Pharma LLC – FDA Inspection, Sep 3, 2021
Record Details
This FDA Inspection record concerns Hybrid Pharma LLC, with an inspection on September 3, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Hybrid Pharma LLC
- Inspection Date
- September 3, 2021
- Product Type
- Drugs
View Company Profile
ID · ba938ba0-4f15-436f-9784-4b4ffdeaf0d9
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1150563
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.192Extent of discrepancy, failure investigations
- 21 CFR 211.194(a)Complete test data included in records
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.170(b)(1)Retention time of reserve samples, in general
- Outsourcing facility, compounded drug report during registration
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hybrid Pharma LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 9, 2023 | OAI | Drug Quality Assurance | |
| June 20, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 28, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hybrid Pharma LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.